share_log
Reuters ·  May 8 16:13
IGM Biosciences Inc - Expects Full Year 2024 Gaap Operating Expenses of $210 Million to $220 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment